Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6076922 | Journal of Investigative Dermatology | 2014 | 8 Pages |
Abstract
The lack of a generally accepted animal model for human psoriasis has hindered progress with respect to understanding the pathogenesis of the disease. Here we present a model in which transgenic IL-17A expression is targeted to the skin in mice, achievable after crossing our IL-17Aind allele to the K14-Cre strain. K14-IL-17Aind/+ mice invariably develop an overt skin inflammation bearing many hallmark characteristics of human psoriasis including dermal infiltration of effector T cells, formation of neutrophil microabscesses, and hyperkeratosis. IL-17A expression in the skin results in upregulated granulopoiesis and migration of IL-6R-expressing neutrophils into the skin. Neutralization of IL-6 signaling efficiently reduces the observed pathogenesis in skin of IL-17A-overexpressing mice, with marked reductions in epidermal neutrophil abscess formation and epidermal thickening. Thus, IL-6 functions downstream of IL-17A to exacerbate neutrophil microabscess development in psoriasiform lesions.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Andrew L. Croxford, Susanne Karbach, Florian C. Kurschus, Simone Wörtge, Alexei Nikolaev, Nir Yogev, Sabrina Klebow, Rebecca Schüler, Sonja Reissig, Carolin Piotrowski, Elke Brylla, Ingo Bechmann, Jürgen Scheller, Stefan Rose-John,